subject area of
- A phase II study of PS-341 (Bortezomib) in advanced or metastatic urothelial cancer. A trial of the Princess Margaret Hospital and University of Chicago phase II consortia Journal Articles
- A phase II trial of sorafenib in first-line metastatic urothelial cancer: a study of the PMH Phase II Consortium Journal Articles
- Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: Assessment of adequate renal function and influence on outcome Journal Articles
- Apoptosis and other effects of radiation in normal human urothelial cells Journal Articles
- Bystander-induced Apoptosis and Premature Differentiation in Primary Urothelial Explants after Charged Particle Microbeam Irradiation Journal Articles
- Bystander-induced differentiation: A major response to targeted irradiation of a urothelial explant model Journal Articles
- Cisplatin-Based First-Line Therapy for Advanced Urothelial Carcinoma After Previous Perioperative Cisplatin-Based Therapy Journal Articles
- Comorbidity Status Does Not Independently Predict Survival Outcomes After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma Journal Articles
- Complete Response as an Intermediate End Point in Patients Receiving Salvage Systemic Therapy for Urothelial Carcinoma Journal Articles
- Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial Journal Articles
- Effect of a tobacco-related nitrosamine on intercellular communication in human urothelial cells: a possible factor in smoking-related bladder carcinogenesis. Journal Articles
- Further Investigation of the Response of Human Uroepithelium to Low Doses of Cobalt-60 Gamma Radiation Journal Articles
- Identification and characterization of three subtypes of radiation response in normal human urothelial cultures exposed to ionizing radiation Journal Articles
- Impact of Response to Prior Chemotherapy in Patients With Advanced Urothelial Carcinoma Receiving Second-Line Therapy: Implications for Trial Design Journal Articles
- Incomplete Cross-Resistance Between Taxanes for Advanced Urothelial Carcinoma: Implications for Clinical Practice and Trial Design Journal Articles
- Individual variation in the production of a `bystander signal' following irradiation of primary cultures of normal human urothelium Journal Articles
- Induction of multiple PCR-SSCPE mobility shifts in exons in cultures of normal human urothelium exposed to low-dose gamma radiation Journal Articles
- Insulin-like growth factors inhibit podocyte apoptosis through the PI3 kinase pathway Journal Articles
- Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study Journal Articles
- Radiation-induced carcinogenesis:Studies using human epithelial cell lines Journal Articles
- Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma Journal Articles
- Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma. Journal Articles
- Stromally Expressed β-Catenin Modulates Wnt9b Signaling in the Ureteric Epithelium Journal Articles
- The Contemporary Role of Lymph Node Dissection During Nephroureterectomy in the Management of Upper Urinary Tract Urothelial Carcinoma: The Canadian Experience Journal Articles
- The Impact of Adding Taxanes to Gemcitabine and Platinum Chemotherapy for the First-Line Therapy of Advanced or Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis Journal Articles
- Trends in utilisation, perioperative outcomes, and costs of nephroureterectomies in the management of upper tract urothelial carcinoma: a 10‐year population‐based analysis Journal Articles
- Urinary bladder xanthoma: a multi‐institutional series of 17 cases Journal Articles